Filing Flows

Filing Flows › Kenvue (KVUE) › Q2 2026 › vs Q1 2026

Kenvue (KVUE) Q2 2026 vs Q1 2026 (quarter over quarter)

Kenvue's revenue rose $46.0M (+1%) from $3.9B in Q1 2026 to $4.0B in Q2 2026. The biggest changes: Self Care −$110M (-6%); Essential Health +$102M (+9%); Skin Health and Beauty +$54.0M (+5%). Gross margin 58.2% against 58.9% (-0.7 pts).

Kenvue, Q2 2026: revenue $4.0B (+3% year over year), operating margin 17.7%, net earnings $456M, operating cash flow $688M. The chart draws each line against Q1 2026, the increases inside each band.

Kenvue: what changed, Q2 2026 vs Q1 2026Kenvue: what changed, Q2 2026 vs Q1 2026Free cash flow (OCF − capex)$274MWorking capital & other$212MOperating cash flow$199MSelf Care−$110MEssential Health$102MCapital expenditures−$75.0MPre-tax earnings−$74.0MOperating profit−$68.0MOperating expenses$67.0MIncome tax−$56.0M

Margins

Q2 2026Q1 2026Change
Gross margin58.2%58.9%-0.7 pts
Operating margin17.7%19.6%-1.9 pts
Net margin11.5%12.1%-0.6 pts
Free cash flow margin15.8%9.0%+6.8 pts

Every line

LineQ2 2026Q1 2026Change%
Self Care$1.6B$1.7B−$110M-6%
Essential Health$1.3B$1.2B$102M+9%
Skin Health and Beauty$1.1B$1.1B$54.0M+5%
Revenue$4.0B$3.9B$46.0M+1%
Gross profit$2.3B$2.3B−$1.0M0%
Cost of revenue$1.7B$1.6B$47.0M+3%
Operating profit$699M$767M−$68.0M-9%
Operating expenses$1.6B$1.5B$67.0M+4%
Pre-tax earnings$598M$672M−$74.0M-11%
Other expense, net$101M$95.0M$6.0M+6%
Net earnings$456M$474M−$18.0M-4%
Income tax$142M$198M−$56.0M-28%
Depreciation & amortization$145M$143M$2.0M+1%
Share-based compensation$32.0M$29.0M$3.0M+10%
Working capital & other$55.0M−$157M$212M—
Operating cash flow$688M$489M$199M+41%
Free cash flow (OCF − capex)$624M$350M$274M+78%
Capital expenditures$64.0M$139M−$75.0M-54%

Questions

How much did Kenvue's revenue grow quarter over quarter in Q2 2026?

Kenvue's revenue rose $46.0M (+1%) from $3.9B in Q1 2026 to $4.0B in Q2 2026.

What drove Kenvue's revenue change in Q2 2026?

Self Care −$110M (-6%); Essential Health +$102M (+9%); Skin Health and Beauty +$54.0M (+5%).

Q2 2026 results → · Compare in the interactive Sankey →